{"schema_version":"secwatch.filing_event.v1","accession":"0001804220-25-000007","form_type":"8-K","ticker":"REGN","cik":"0000872589","company_name":"REGENERON PHARMACEUTICALS, INC.","filed_at":"2025-02-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.565492+00:00","generated_at":"2026-05-27T03:47:58.993759+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Regeneron Q4 revenue up 10% to $3.79B; initiates $0.88 quarterly dividend, adds $3B buyback","bullets":["Q4 GAAP diluted EPS $8.06 (-21% YoY); non-GAAP diluted EPS $12.07 (+2% YoY). Full year revenue $14.20B (+8%).","Q4 Dupixent global net sales $3.70B (+15%); EYLEA HD/EYLEA US net sales $1.50B (+2%); Libtayo global $367M (+50%).","Initiated quarterly cash dividend of $0.88/share, payable March 20, 2025. Board authorized additional $3.0B share repurchase (total capacity ~$4.5B).","Regulatory applications submitted for EYLEA HD pre-filled syringe, Dupixent in bullous pemphigoid, linvoseltamab, and odronextamab."],"urls":{"canonical":"https://secwatch.observer/filing/0001804220-25-000007","json":"https://secwatch.observer/filing/0001804220-25-000007.json","markdown":"https://secwatch.observer/filing/0001804220-25-000007.md","text":"https://secwatch.observer/filing/0001804220-25-000007.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/872589/000180422025000007/0001804220-25-000007-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/872589/000180422025000007/regn-20250204.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T03:47:58.993759+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}